Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human papillomavirus DNA load and p16INK4aexpression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
Franz Rödel, Ulrike Wieland, Ingeborg Fraunholz, et al.
International Journal of Cancer (2014) Vol. 136, Iss. 2, pp. 278-288
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
Didier Meulendijks, N B Tomasoa, L. Dewit, et al.
British Journal of Cancer (2015) Vol. 112, Iss. 8, pp. 1358-1366
Open Access | Times Cited: 102
Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
Panagiotis Balermpas, Daniel Martin, Ulrike Wieland, et al.
OncoImmunology (2017) Vol. 6, Iss. 3, pp. e1288331-e1288331
Open Access | Times Cited: 98
High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis
Ivona Baričević, Xiaotong He, Bipasha Chakrabarty, et al.
European Journal of Cancer (2015) Vol. 51, Iss. 6, pp. 776-785
Closed Access | Times Cited: 84
Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer
Duncan C. Gilbert, Eva Serup‐Hansen, Dorte Linnemann, et al.
British Journal of Cancer (2016) Vol. 114, Iss. 2, pp. 134-137
Open Access | Times Cited: 78
Human papillomavirus and gastrointestinal cancer: A review
Dania Bucchi, Fabrizio Stracci, N. Buonora, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 33, pp. 7415-7415
Open Access | Times Cited: 61
Influence of human papillomavirus and p16INK4a on treatment outcome of patients with anal cancer
Stefan A. Koerber, Clara Schoneweg, Alla Slynko, et al.
Radiotherapy and Oncology (2014) Vol. 113, Iss. 3, pp. 331-336
Open Access | Times Cited: 64
Biomarkers in anal cancer: from biological understanding to stratified treatment
Christopher M. Jones, Vicky Goh, David Sebag‐Montefiore, et al.
British Journal of Cancer (2016) Vol. 116, Iss. 2, pp. 156-162
Open Access | Times Cited: 54
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
Wulfran Cacheux, Étienne Rouleau, Adrien Briaux, et al.
British Journal of Cancer (2016) Vol. 114, Iss. 12, pp. 1387-1394
Open Access | Times Cited: 53
Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma
Stephan Herberhold, Martin Hellmich, Marcus Panning, et al.
Medical Microbiology and Immunology (2016) Vol. 206, Iss. 2, pp. 93-103
Closed Access | Times Cited: 47
Detection of alpha human papillomaviruses in archival formalin-fixed, paraffin-embedded (FFPE) tissue specimens
Boštjan J. Kocjan, Lea Hošnjak, Mario Poljak
Journal of Clinical Virology (2015) Vol. 76, pp. S88-S97
Closed Access | Times Cited: 41
Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8
Christina Helmke, Monika Raab, Franz Rödel, et al.
Cell Research (2016) Vol. 26, Iss. 8, pp. 914-934
Open Access | Times Cited: 39
Prognostic Significance of HPV DNA and p16INK4a in Anal Cancer: A Systematic Review and Meta-Analysis
Aivara Urbutė, Christina Louise Rasmussen, F. Belmonte, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 4, pp. 703-710
Closed Access | Times Cited: 35
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M. Huffman, Harshabad Singh, Lestat R. Ali, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008436-e008436
Open Access | Times Cited: 4
The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy
Daniel Martin, Franz Rödel, Panagiotis Balermpas, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 1, pp. 221-230
Closed Access | Times Cited: 38
High-grade Dysplasia in Anogenital Warts of HIV-Positive Men
Alexander Kreuter, C. Siorokos, Frank Oellig, et al.
JAMA Dermatology (2016) Vol. 152, Iss. 11, pp. 1225-1225
Open Access | Times Cited: 36
Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response
Cristian R. Cleary, Jonathan E. Leeman, Daniel S. Higginson, et al.
Clinical Oncology (2016) Vol. 28, Iss. 7, pp. 467-474
Open Access | Times Cited: 35
The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers
Sophie Otter, S. Whitaker, Jayanta Chatterjee, et al.
Clinical Oncology (2018) Vol. 31, Iss. 2, pp. 81-90
Open Access | Times Cited: 35
Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016
Marianne G. Guren, Bjarte Aagnes, Mari Nygård, et al.
Clinical Colorectal Cancer (2018) Vol. 18, Iss. 1, pp. e96-e103
Closed Access | Times Cited: 33
Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma
Bahir Chamseddin, Eunice E. Lee, Jiwoong Kim, et al.
Oncotarget (2019) Vol. 10, Iss. 57, pp. 5958-5969
Open Access | Times Cited: 31
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer
Franz Rödel, Maximilian Fleischmann, Markus Diefenhardt, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Characterization of key transcription factors as molecular signatures of HPV‐positive and HPV‐negative oral cancers
G. S. Verma, Kanchan Vishnoi, Abhishek Tyagi, et al.
Cancer Medicine (2017) Vol. 6, Iss. 3, pp. 591-604
Open Access | Times Cited: 32
Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
Daniel Martin, Franz Rödel, Ria Winkelmann, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 32
The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis
Guorui Sun, Xiao‐yuan Dong, Xiaolong Tang, et al.
Oncotarget (2017) Vol. 9, Iss. 8, pp. 8081-8088
Open Access | Times Cited: 30
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Daniel Martin, Franz Rödel, Stephanie Hehlgans, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 3
C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
Daniel Martin, Franz Rödel, Panagiotis Balermpas, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top